Flexion Therapeutics (FLXN) PT Lowered to $18 at Laidlaw
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts FLXN Hot Sheet
Price: $23.90 --0%
Rating Summary:
11 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
11 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Laidlaw analyst Francois Brisebois lowered the price target on Flexion Therapeutics (NASDAQ: FLXN) to $18.00 (from $25.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Modine Manufacturing (MOD) PT Lowered at KeyBanc on 'Margin Headwinds'
- Hypera SA (HYPE3:BZ) (HYPMY) PT Lowered to R$28.50 at UBS
- Jalles Machado SA (JALL3:BZ) PT Lowered to R$2.80 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
